Welcome to Scribd. Sign in or start your free trial to enjoy unlimited e-books, audiobooks & documents.Find out more
Download
Standard view
Full view
of .
Look up keyword
Like this
1Activity
0 of .
Results for:
No results containing your search query
P. 1
PCORI’s Interests in Patients with Multiple Co-morbid Conditions

PCORI’s Interests in Patients with Multiple Co-morbid Conditions

Ratings:
(0)
|Views: 300|Likes:
Presentation by Dr. Peter Selby, PCORI Executive Director, at PFCD's Hill Briefing "Implications of Growing Prevalence of Multiple Chronic Conditions: Needs Great, Evidence Lacking"
Presentation by Dr. Peter Selby, PCORI Executive Director, at PFCD's Hill Briefing "Implications of Growing Prevalence of Multiple Chronic Conditions: Needs Great, Evidence Lacking"

More info:

Published by: Partnership to Fight Chronic Disease on Apr 24, 2013
Copyright:Attribution Non-commercial

Availability:

Read on Scribd mobile: iPhone, iPad and Android.
download as PDF, TXT or read online from Scribd
See more
See less

05/14/2014

pdf

text

original

 
Joe Selby MD, MPHPCORI Executive Director  April 23, 2013
 
PCORI’s Interests in Patients withMultiple Co-morbid Conditions
 
Source: Affordable Care Act. Subtitle D—Patient-Centered Outcomes Research.PUBLIC LAW 111–148—MAR. 23, 2010.
“ 
The purpose of the Institute is to assistpatients, clinicians, purchasers, and policy-makers in making informed health decisions…. concerning the manner in whichdiseases, disorders, and other healthconditions can effectively and appropriatelybe prevented, diagnosed, treated,monitored, and managed through researchand evidence synthesis that considersvariations in patient subpopulations ….withrespect to the relative health outcomes,clinical effectiveness, and appropriatenessof medical treatments, services.
PurposeOf PCORI
PCORI’s Mandate
 
3
Source: Affordable Care Act. Subtitle D—Patient-Centered Outcomes Research.PUBLIC LAW 111–148—MAR. 23, 2010.
“ 
Research shall be designed, asappropriate, to take into account thepotential for differences in theeffectiveness of health care treatments,services, and items as used withvarious subpopulations, such as racialand ethnic minorities, women, age, andgroups of individuals with differentcomorbidities, genetic and molecular sub-types, or quality of life preferencesand include members of suchsubpopulations as subjects in theresearch as feasible and appropriate.
 Appreciating Patient DifferencesThe Legislation re: Treatment Heterogeneity

You're Reading a Free Preview

Download
scribd
/*********** DO NOT ALTER ANYTHING BELOW THIS LINE ! ************/ var s_code=s.t();if(s_code)document.write(s_code)//-->